In addition, HDAC inhibitors have potential applications for non-malignant disease: initial pre-clinical studies show efficacy of multiple HDAC inhibitors for the treatment of cardiovascular disease and diabetes [12,13,14]. Here, HDAC9 is linked to cardiovascular disorder.